Hide Board Information

Show Board Information

PharmaCyte Biotech Inc. PMCB

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/15/2023 8:10:49 AM

Board Marks: 56

Posts Today: 0

Board Views Today: 152

PharmaCyte Biotech Inc. (NASDAQ: PMCB) Stock Message Board

1. PMCB Company Profile

    

2. PMCB Time & Sales

    

3. PMCB Recent News

    

4. PMCB Filings

    

5. PMCB Financials

    

6. PMCB Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

440	$NVLX Nuvilex Begins Making Moves at its	stocklegend	02/14/2014 9:19:43 AM
439	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	02/14/2014 8:51:35 AM
438	$NVLX Nuvilex COO Talks About Companys	stocklegend	02/13/2014 3:54:44 PM
437	$NVLX Nuvilex, Inc. Featured on Forbes:	stocklegend	02/13/2014 3:33:31 PM
436	$NVLX Nuvilex Listed in Forbes Article on	stocklegend	02/13/2014 1:01:48 PM
435	$NVLX - Nuvilex COO Talks Medical Marijuana in	stocklegend	02/13/2014 12:30:55 PM
434	$NVLX - Nuvilex Featured in Forbes and NY Post	stocklegend	02/13/2014 11:35:29 AM
433	$NVLX - Nuvilex Acquires Cancer Cell	stocklegend	02/13/2014 11:18:47 AM
432	$NVLX - Nuvilex Acquires Cancer Technology, Next	stocklegend	02/13/2014 9:58:15 AM
431	$NVLX - Nuvilex Restructures to Focus on	stocklegend	02/13/2014 9:51:41 AM
430	$NVLX - Nuvilex Contracts with Inno Biologics to	stocklegend	02/13/2014 9:04:45 AM
429	Nuvilex, Inc. ($NVLX) shares closed up 6.87	Tandrel	02/13/2014 8:57:38 AM
428	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	02/13/2014 8:49:51 AM
427	$NVLX Nuvilex COO Talks About Companys	stocklegend	02/12/2014 2:16:34 PM
426	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	02/12/2014 1:50:35 PM
425	$NVLX Inno Biologics Begins Cell Cloning	stocklegend	02/12/2014 1:17:20 PM
424	$NVLX Nuvilex Announces Cloning of Cells for	stocklegend	02/12/2014 12:37:21 PM
423	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	02/12/2014 12:23:38 PM
422	The live-cell encapsulation technology employed	jschrager23	02/12/2014 11:46:36 AM
421	NEW YORK, NY--(Marketwired - Feb 12, 2014) -	jschrager23	02/12/2014 11:46:01 AM
420	HUGE NEWS OUT TODAY!	jschrager23	02/12/2014 11:45:38 AM
419	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	02/12/2014 11:16:30 AM
418	$NVLX is doing well today! Back in the green with	Tandrel	02/12/2014 10:42:49 AM
417	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	02/12/2014 10:34:39 AM
416	Nuvilex just released news! The transcript of a	Tandrel	02/12/2014 10:06:40 AM
415	$NVLX Nuvilex Begins Making Moves at its	stocklegend	02/12/2014 10:04:38 AM
414	NVLX news:	stocklegend	02/12/2014 9:41:47 AM
413	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	02/12/2014 8:59:23 AM
412	$NVLX Inno Biologics Begins Cell Cloning	stocklegend	02/11/2014 3:02:38 PM
411	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	02/11/2014 2:12:45 PM
410	$NVLX Nuvilex COO Talks About Companys	stocklegend	02/11/2014 2:07:56 PM
409	$NVLX Nuvilex, Inc. Featured on Forbes:	stocklegend	02/11/2014 1:34:03 PM
408	$NVLX Nuvilex Listed in Forbes Article on	stocklegend	02/11/2014 12:59:23 PM
407	$NVLX - Nuvilex COO Talks Medical Marijuana in NY	stocklegend	02/11/2014 11:37:40 AM
406	$NVLX - Nuvilex Featured in Forbes and NY Post	stocklegend	02/11/2014 10:52:45 AM
405	$NVLX - Nuvilex Acquires Cancer Cell	stocklegend	02/11/2014 10:24:06 AM
404	$NVLX - Nuvilex Acquires Cancer Technology, Next	stocklegend	02/11/2014 10:05:32 AM
403	$NVLX - Nuvilex Restructures its Operations to	stocklegend	02/11/2014 9:43:35 AM
402	$NVLX - Nuvilex Restructures to Focus on	stocklegend	02/11/2014 9:25:17 AM
401	$NVLX - Nuvilex Contracts with Inno Biologics to	stocklegend	02/11/2014 9:14:19 AM
400	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	02/11/2014 9:00:22 AM
399	$NVLX Nuvilex Announces Cloning of Cells for	stocklegend	02/10/2014 3:54:04 PM
398	$NVLX Nuvilex Completes Acquisition of	stocklegend	02/10/2014 3:16:57 PM
397	$NVLX Nuvilex Accelerates Development of	stocklegend	02/10/2014 2:27:48 PM
396	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	02/10/2014 2:07:13 PM
395	$NVLX Nuvilex Ahead of the Curve on	stocklegend	02/10/2014 1:18:05 PM
394	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	02/10/2014 12:32:35 PM
393	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	02/10/2014 11:49:53 AM
392	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	02/10/2014 11:08:37 AM
391	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	02/10/2014 10:13:18 AM

Newer

Older

Recent Articles

• BioLineRx's Q3 2024 Financial Performance Highlights
• LSL Pharma Group Reports Impressive Q3-24 Financial Growth
• Veea's Innovative Farming Technology Revolutionizes Agriculture
• Innovative Partnership Between Smartkem and AUO for Displays
• Mubadala Capital Moves to Acquire CI Financial in Major Deal
• UK Households Brace for Tight Budgets This Holiday Season
• Bybit and DMCC Celebrate Innovative Blockchain Projects Worldwide
• Anzen Launches $ANZ Token Sale to Boost DeFi Engagement
• U-BX Technology Ltd. Implements 1-for-16 Reverse Stock Split
• Innovative Web3 Projects Unveiled at Bangkok Hacker House Event
• Clearside Biomedical Showcases Innovative Eye Therapy Advances
• Innovative Collaboration for Next-Gen Rollable MicroLED Displays
• Seraph Unveils Ambitious Blockchain Gaming Futures at Events
• Clearside Biomedical Advances Revolutionary Eye Treatment Tech
• Mobix Labs Strategically Expands through Spacecraft Components Buyout
• AstraZeneca Breakthrough: TRUQAP's Promise in Cancer Care
• Boston Scientific's Strategic Acquisition of Intera Oncology
• TransCode Therapeutics Approves Key Reverse Stock Split Strategy
• Semler Scientific Expands Bitcoin Strategy and ATM Offerings
• Rocket Lab's Major Award Boosts Semiconductor Manufacturing
• Innovative Advances in Glioblastoma Treatment by IN8bio
• Replimune's Bold Move: $125 Million Offering to Fuel Growth
• Optimistic TSX Futures Surge as Economic Insights Loom
• Old National Bancorp's $1.4 Billion Acquisition of Bremer Financial
• Quikrete's Major Acquisition of Summit Materials for $11.5 Billion
• Macy's Faces Challenges with Q3 Performance and Sales Declines
• Bath & Body Works' Strong Q3 Performance Boosts Future Outlook
• Key Insights on Gold Price Decline and Economic Trends
• Brightstar Capital Partners Welcomes Charles Yoon as New Partner
• GURU Organic Energy Shifts Distribution Strategy Away from PepsiCo
• Boundless Bio's Upcoming Appearance at Healthcare Conference
• Forecasting Growth in the Industrial Ethernet Sector Through 2028
• Insight into Recent Cash Distributions by JPMorgan ETFs
• Shattuck Labs to Showcase Innovations at December Investor Events
• Swvl Partners with HSBC for Sustainable Expansion and Growth
• Automobile Engine Manufacturing Market Set for Booming Growth
• Kanglin Biotechnology Secures $20 Million to Advance Gene Therapies
• Opthea Set to Engage Investors at a Major Healthcare Conference
• Exploring the Future of Property Management Software Sector
• Nurix Therapeutics Prepares for Key Healthcare Conference Appearance
• Strategic Resources Secures Major Iron Ore Supply Deals and Financing
• Optimistic Market Trends as Investors Embrace Economic Insights
• Nvidia's Deep Roots in China's Tech Landscape Drive AI Success
• Bath & Body Works Exceeds Expectations in Q3 2024 Performance
• Schroders PLC Updates Stake in Sosandar PLC: Key Insights
• Warren Buffett's Generous Philanthropy and Wealth Management
• Quikrete's Strategic Move: Acquiring Summit Materials for $11.5B
• Coinsilium Group Limited Plans Upcoming Annual Shareholder Meeting
• Thungela Resources Executives Liquidate Shares for Tax Reasons
• Ananda Developments Unveils Breakthrough CBD Research Insights